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Abstract
Immunization can and does save lives. However, the presence of vaccines does not easily translate
into every child being vaccinated, and this is what the studies in this journal supplement reveal.
From South Asia to West Africa,the evidence presented here reveals what we are calling the fallacy
of coverage, going beyond uncovering the real vaccination rates to providing evidence on the
reasons for the lack of effective coverage.
The evidence for the fallacy of coverage is part of an operational research program entitled the
Canadian International Immunization Initiative Phase 2 (CIII2).Through a competitive peer review
process,six research grants were awarded to increase access to and enhance immunization services.
This journal supplement provides a forum for the presentation of the results of five of the six studies.
The story of the fallacy of coverage is made up of five theme areas of evidence – timeliness of
immunization, social and gender inequities, vaccine efficacy, understanding demand side issues to
tailor interventions,and national data sets masking actual district level coverage rates – that reveal
the discrepancies in immunization coverage rates and the reasons behind these discrepancies.As
part of the story, and to turn around the fallacy of coverage, the studies also provide proof of
effective and locally relevant solutions.
Policies and funding,while keeping an eye on future diseases,clearly need to maintain and increase
support to address existing vaccine-preventable diseases  to increase coverage such that by 2015
we can achieve 90% national vaccination coverage and reach the MDG of reducing mortality rates
among children under five by two-thirds.The results from the operational research grants of the
CIII2 offer some answers on how to reach this goal by demonstrating how locally generated
evidence can inform immunization strategies to ensure that children who need to get vaccinated
will get vaccinated, and vaccinated on time.
Open AccessIntroduction
Immunization can and does save lives. With existing
vaccines, it is estimated that between two and three
million deaths from diphtheria, tetanus, pertussis and
measles are prevented annually [1]. There is a strong
global recognition that increasing immunization coverage
is an essential step towards reducing child mortality, the
fourth Millennium Development Goal (MDG). Currently
as a response, the chief goal set by UNICEF and WHO is
to, by 2015 or earlier, reduce illness and death due to
vaccine-preventable diseases by at least two thirds
compared to 2000 levels.
Examination of the top three vaccine-preventable diseases
in all regions of the world reveals the importance of
focusing efforts on increasing coverage of existing
vaccines (See Table 1). However, the presence of vaccines
does not easily translate into every child being vaccinated,
and this is what the studies in this journal supplement
reveal. While progress is being made with global agencies
reporting coverage rates of 81% for infants receiving three
doses of diphtheria, pertussis and tetanus (DPT3) [2] and
measles vaccination reaching 80% [3], the articles in this
journal supplement reveal great disparities among and
within countries. As such, from South Asia to West Africa
the evidence presented here reveals what we are calling
the fallacy of coverage. The studies in this supplement go
beyond uncovering the real vaccination rates to providing
evidence on the reasons for the lack of effective coverage.
Some go as far as introducing locally-relevant
interventions that actually improve the coverage rates of
measles and DPT3 [4,5].
The evidence for the fallacy of coverage is part of an
operational research program entitled the Canadian
International Immunization Initiative Phase 2 (CIII2),
initiated in September 2003. This initiative is a project of
the Global Health Research Initiative (GHRI), which
involves the collaboration of five major research/health
agencies in Canada: International Development Research
Centre (IDRC), Canadian International Development
Agency (CIDA), Canadian Institutes of Health Research
(CIHR), Health Canada (HC) and the Public Health
Agency of Canada (PHAC). It is an important precedent
of funding organizations coming together, pooling
resources and strengths, to invest in filling the gaps in
immunization research.
Through a competitive peer review process, six research
grants were awarded to increase access to and enhance
immunization services in CIDA’s priority countries. This
journal supplement in BioMed Central’s open access
journal  BMC International Health and Human Rights
provides a forum for the presentation of the results of five
of the six studies. 
The first paper that follows provides a global overview of
the progress to date in immunization and some of the
challenges from the CIII2 partners. It discusses the various
approaches used by WHO and UNICEF to improve
immunization coverage and at the same time sets the
stage for the research results of the CIII2 operational
research grants by impressing on the need for evidence to
realise the full “potential of immunization…in achieving
the health-related MDGs”[6]. 
The subsequent 13 peer-reviewed papers unravel the
fallacy of coverage and present the evidence for what is
needed to get closer to achieving the fourth MDG. All the
studies underline the importance of understanding the
context in which the extent of immunization coverage is
realised. Only through such operational and local
research can we get the needed evidence to improve
coverage – from South Asia to West Africa. 
Theme areas of evidence
The story of the fallacy of coverage is made up of five theme
areas of evidence that reveals the discrepancies in
immunization coverage rates and the reasons behind
these discrepancies. It also includes evidence for turning
around this fallacy of coverage. The first theme is the
challenge of timeliness or age-appropriate immunization.
This is evident in the studies presented in this supplement
from India [7], Pakistan [4,8], and Burkina Faso [9,10]. By
assessing coverage through the analytical lens of age-
appropriateness of coverage, these studies bring into
question the progress of immunization coverage. In fact,
as seen by the evidence, while overall coverage can be
deceptively good, the story changes when one takes into
account whether or not vaccines are administered on
time. In India for example, while immunization coverage
has overall increased, the work by Corsi et al. [7] shows
that, nationally, complete age-appropriate coverage is still
under 50%. Not only do age-appropriate immunization
rates provide a truer picture of actual coverage, but such
an approach is also useful for health workers and service
providers – as noted in the work by Dugas et al. [9] and
Bicaba et al. [10] – as it allows them to improve and tailor
their immunization strategies to increase coverage. The
implications for not providing immunization on time are
reduced benefit of the vaccine and increased mortality.
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Table 1 -Top vaccine-preventable diseases by region.
Region Diseases
South Asia  Measles,Tetanus, Pertussis
South-East Asia Pertussis, Measles, Hep B
Latin America & Caribbean Pertussis,Tetanus, Hep B
Sub-Saharan Africa  Measles, Pertussis,Tetanus
Source: http://www.worldbank.org/features/2006/tabledcpp.htm.The critical importance of the timely immunization
theme was recently detailed in a review of data from 45
low-income and middle-income countries published in
the Lancet [11]. 
The next key theme area of evidence to better understand
the  fallacy of coverage is the issue of social and gender
equity. Work by Corsi et al. [7] demonstrates that the
progress of immunization coverage in India is hindered
by the persistence of gender inequities across all socio-
economic levels, resulting in girls having significantly
lower coverage rates for bacille Calmette-Guérin (BCG),
oral polio vaccine (OPV), DPT and measles vaccination.
Interestingly, gender inequities affect who gets
immunized or not, but does not affect the decision to
immunize on time. Gender also needs to be considered in
targeting interventions, as demonstrated through an in-
depth ethnographic study by Dugas et al. [9] in Burkina
Faso. The researchers found that in some communities
despite the father’s decision to vaccinate the children,
mothers do not always bring them to be immunized. This
gap between decision-making and actual vaccination
practice requires interventions that target both parents.
The linkage between poor coverage and increasing
inequities is demonstrated in the studies in Pakistan and
Burkina Faso. Mitchell et al. [8]  provide evidence on how
poor access and mother’s education (in urban areas only)
were the key equity factors obstructing measles
vaccination uptake in the Lasbela district of Pakistan. In
the Nouna district of Burkina Faso, Sanou et al. [12]
provide evidence for how the education of both parents
along with the economic conditions of households
affected immunization coverage. The authors did note,
however, that the influence of economic conditions is
complex as immunization services are free of charge, thus
pointing to the importance of communication about the
free services to avoid potential abuses by providers.
In addition to inappropriate coverage and increasing
inequities linked to coverage, the Pakistan study
uncovered the next key theme area, which is that of
vaccine efficacy. Through the development of a
communication tool (a “balance sheet” summarizing
published evidence on benefits and possible adverse
effects of vaccination) to enable communities to balance
costs and benefits of measles vaccination, Ledogar et al.
[13] uncovered a much lower vaccine efficacy rate in
Lasbela, Pakistan, than expected. As such, the rate they
found was 41.5% compared to the rate generally found in
developed countries of 95% (range of 90-98%) [14].
Reasons for this discrepancy are discussed in the paper.
While this “balance sheet” was not used in the
randomised controlled trial of a community intervention
in Lasbela, Pakistan, such a tool could serve as a web-
based reference for project managers and health officials,
helping them identify areas of improvement in
immunization services. 
Many of the articles in this supplement offer a strong
demand side perspective, i.e. from existing and potential
beneficiaries. This demand side evidence is the next key
theme area which looks behind the discrepancies in
vaccination rates to help tailor potential solutions. In the
Pakistan series of articles, Shea et al. [15] conducted a
systematic review of the literature on the impact of
demand side interventions, demonstrating existing gaps
and highlighting the need for such operational research.
By focusing on the demand side, Dugas et al. [9] provide
an increased understanding of why there is a lower than
expected coverage rate in a health district in Burkina Faso.
Their study points to the need to tailor interventions such
that they take into account parents’ perception of childhood
illness and to the need to examine local vaccination
procedures or requirements. In this particular case, their
research found that vaccination procedures served to
deter rather than ensure access. In practice, immunization
access was conditional on women going for antenatal care
and acquiring and preserving a vaccination booklet for
their child. In the same vein, Bicaba et al. [10] argue for
the importance of understanding the reasons why some
children are still not completely vaccinated. 
As part of a demand side analysis, understanding the local
context is one of the keys to unravel the fallacy of coverage.
Fourn et al. [16] in Benin ask the question: what are the
factors that lead to reticence to vaccination among
religious populations? Through the use of qualitative
methods, their results suggest that interpretation of
religious principles by church-going populations is
primary in explaining reticence and that the solutions lie
in  creating an open dialogue among all actors: reticent
parents, their religious leaders and health authorities.
Such an intervention is also alluded to by the work in
Burkina Faso by Sanou et al. [12] and national EPI teams
have used the results of the study. 
The local level analyses also provide valuable information
on existing immunization programs/campaigns. For
example, Mitchell et al. [8] note that while other areas in
Pakistan have demonstrated the positive impact of
mobile vaccination teams, this was not the case in Lasbela
district. Similarly, as seen in Burkina Faso, Haddad et al.
[17] note that Immunization Days did not have any
impact on the performance of routine vaccination
services. While both authors discuss this finding in their
papers, it is worthy to note that these results from South
Asia to West Africa further underscore that blueprint
national programs/campaigns often do not resonate with
communities as their assumptions are disconnected from
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programs/campaigns to increase their effectiveness. 
The studies in this supplement provided evidence from a
local/district level and also compared their results to
national data sets, thus presenting the last key theme area
with regards to the fallacy of coverage. In the article by
Cockroft et al. [18] the authors unravel a complex context
where actual coverage rates are masked by national rates,
and where there is heterogeneity in vaccination coverage
between and within districts, and particularly between
urban and rural areas in Pakistan. Despite this
heterogeneity, as Cockroft et al. [18] point out, there is
some  commonality in the variables associated with
vaccination uptake such as the quality of services, mother’s
education and knowledge of benefits. Local evidence on
these issues can then be used to turn around the fallacy of
coverage, thereby increasing immunization uptake. 
Evidence of locally relevant solutions
Beyond the five key theme areas of evidence that emerge
from this supplement, the various studies also highlight
effective and locally relevant solutions that can lead to
increased immunization coverage rates. This was the case
in Pakistan, where as detailed by Andersson et al. [4],
researchers addressed the challenge of low measles
coverage rates in Lasbela district by introducing an
intervention involving an evidence-based and structured
series of community discussions of vaccination’s costs and
benefits. The effect of this intervention was tested using a
randomised controlled trial without relying on improved
health services. In fact, through this operational research
the team, working with communities and health workers,
doubled the odds of measles vaccination uptake (20%
increase) and tripled the odds of completing full DPT
vaccination (29% increase) for this district. The Pakistan
study thus provides evidence on how to improve the
demand side of vaccination uptake at a relatively low cost
(US$9 per child). Interestingly, the work in Mali by
Koumaré et al. [19] and in Burkina Faso by Sanou et al. [12]
similarly underscore the need to give priority to providing
information to communities on the goals of immunization as
well as the importance of tailoring interventions to local
realities to improve immunization uptake. 
The evidence also points to the fact that improving
coverage rates requires work not only on the demand side,
but also on the supply side. As noted by Andersson et al.
[4] in discussing the low efficacy rate of measles vaccine
in Lasbela, Pakistan, improving service quality is needed
to improve efficacy rates. As part of improving supply, the
article by Djibuti et al. [20] focuses on health care
providers and immunization managers in Georgia,
documenting the effects of “supportive” supervision on
the performance of the immunization program at the
district level. Not surprisingly, within a framework of
national immunization programs, such provider-based
interventions can have a positive effect on coverage. 
Finally, the last piece of evidence to help turn around the
fallacy of coverage comes from the work by Haddad et al.
[17],  which focuses on system-related factors to explain
disparities in immunization coverage among districts in
Burkina Faso. By looking at a combination of factors (such
as donor support, staffing standards, local strategies,
immunization days and leadership by the district medical
officer (DMO)) and their interaction, the authors
conclude that the key is the “human factor” and the ability
of  good leadership to create the conditions for good
performance. Even with limited access to donor supported
initiatives or the presence of seasonal epidemics, with
strong and committed leadership districts can adapt and
perform well. Local strategies, as also demonstrated in the
other studies, are also important and become more
effective when linked to strong DMO leadership. 
Concluding comments
The articles are organised according to geography and
research teams, starting in India and ending in Burkina
Faso. Though, clearly the evidence repeats itself from
South Asia to West Africa. Through locally based
operational research, the story of the fallacy of coverage is
revealed. Timeliness of immunization, social and gender
inequities, vaccine efficacy, understanding demand side
issues to tailor interventions, and national data sets
masking actual district level coverage rates are the key
theme areas of evidence. As part of the story, and to turn
around the fallacy of coverage, the studies also provide
proof of effective and locally relevant solutions:
introducing structured series of community discussions
on the cost-benefit of immunization, the role of
supportive supervision and the role of strong leadership. 
And such is the story of the fallacy of coverage, from South
Asia to West Africa. The challenge now is how to build on
the strength of the results and translate the evidence to
global and national policies, programs and funding. This
journal supplement is one step in that direction. At the
same time, and as detailed by Duclos et al. [6], funding
for improving immunization focuses not only on
increasing coverage, but also on future diseases and
vaccines. While it is important to keep an eye on future
diseases, there is strong evidence – to which this
supplement contributes – for the need to maintain and
increase support to address existing vaccine-preventable
diseases. While overall improvements in global coverage
rates are undoubtedly taking place, in 2002 alone, it is
estimated that 1.5 million children in all age groups died
from diseases preventable by vaccines currently
recommended by WHO (excluding measles) [21]. In
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and regions, but also within countries and districts. Thus,
the question arises on how best to allocate funds to
increase coverage such that by 2015 we can achieve 90%
national vaccination coverage and reach the MDG of
reducing mortality rates among children under five by
two-thirds. The results from the operational research
grants of the CIII2 offer some answers by demonstrating
how locally generated evidence can inform immunization
strategies to ensure that children who need to get
vaccinated will get vaccinated, and  vaccinated on time. We
are making progress, however we still have a way to go.
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